Trial Profile
Study of the effect of direct/grid laser photocoagulation and intravitreal ranibizumab in patients with macular edema following retinal vein occlusion
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Jan 2022
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- 27 Jan 2015 New trial record